Introduction
Barbiturates are widely used as sedatives, hypnotics, and antiepileptics, and sometimes cause death in suicides and
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Bayer HealthCare (Leverkusen, Germany), and Fujinaga Pharmaceutical (Tokyo, Japan), respectively. Oasis HLB extraction cartridges were purchased from Waters (Milford, MA, USA). Other common chemicals used were of the highest purity commercially available. Pure water having a specifi c resistance of 17 MΩ cm was used for sample preparation and as the HPLC mobile phase.
Blank urine samples were collected from a healthy adult and kept frozen at −20°C until analyzed. Barbiturate-positive urine samples were obtained from male and female cadavers at forensic autopsies and were stored at −80°C.
HPLC conditions
The analytical column was a PIPAAm hydrogelmodifi ed column (150 × 4.6 mm i.d.) (CellSeed, Tokyo, Japan). The column was connected to an HPLC system consisting of a pump (LC-10AD), an ultraviolet-visible detector (SPD-10A), and an autosampler (SIL-20A) (Shimadzu, Kyoto, Japan). The column oven was an Aqua Way Gradienter (CellSeed). The mobile phase was 2.5 mM ammonium formate buffer adjusted to pH 7.5 with ammonium hydroxide. The elution was monitored at 215 nm at a fl ow rate of 1 ml/min at 50°C.
Procedure
A 1-ml volume of urine containing barbiturate and secobarbital as IS (8 μg) was mixed with 1 ml of distilled water. The diluted urine sample was loaded onto a conditioned Oasis HLB cartridge. It was washed with 2 ml of 5% methanol in distilled water and 2 ml of 2% acetic acid in 25% methanol; the target compounds were eluted with 2 ml of 2% ammonium hydroxide in 35% methanol. The eluate was dried using a Savant SpeedVac system (Savant, Holbrook, NY, USA). The resultant residue was dissolved in 200 μl of mobile phase and a 20-μl volume was injected into the HPLC system by the autosampler.
Results and discussion
Separation of barbiturates with the thermoresponsive column As shown in Fig. 2 , the retention times and separation of barbiturates could be controlled only by changing the column temperature from 10°C to 50°C in the isocratic elution mode. At 10°C, only metharbital and primidone could be separated from other barbiturates, but the peaks of phenobarbital, mephobarbital, pento- barbital, and secobarbital (IS) were overlapped. By elevating the column temperature, the retention times of mephobarbital, pentobarbital, and secobarbital were increased and the overlapped peaks gradually separated into four peaks. Therefore, we chose 50°C as the column temperature for detection of the six barbiturates including IS.
Reliability of the method Table 1 shows regression equations and correlation coeffi cients for fi ve barbiturates spiked into human urine at concentrations of 0.2, 1, 5, and 10 μg/ml. All calibration curves exhibited good linearity in the range of 0.2-10 μg/ml with r values not smaller than 0.994. The limits of detection (single-to-noise ratio = 3) for metharbital, primidone, phenobarbital, mephobarbital, and pentobarbital were 0.2, 0.2, 0.1, 0.1, and 0.1 μg/ml, respectively. Intraday accuracy and coeffi cients of variation (CV), and recoveries for fi ve barbiturates spiked into human urine at concentrations of 0.2, 1, and 5 μg/ml are shown in Table 2 . The recoveries were calculated by comparing the peak areas obtained from the extracts of the spiked urine with those obtained by direct HPLC injection of nonextracted compounds dissolved in distilled water. Intraday accuracy of metharbital, primidone, and mephobarbital at 0.2 μg/ml was not smaller than 135%; the CV values at this concentration were also relatively high for metharbital and primidone. The high accuracy may be due to interference by impurity peaks of blank urine, especially at the low barbiturate concentration. At 1 and 5 μg/ml, however, both accuracy and CV values (precision) were within the acceptable range. The recovery rates of barbiturates tested were generally satisfactory at all concentrations.
Application of the method to actual human samples The described method was applied to barbiturate measurements in actual cases. Both subjects were suspected of ingesting tablets containing phenobarbital. Figure 3 shows an HPLC chromatogram of urine extract from The subject was suspected of ingesting tablets containing phenobarbital. The cadaver urine was diluted tenfold with blank urine before extraction, because the phenobarbital level was too high and beyond the calibration curve range. Peaks: 1, phenobarbital; 2, secobarbital (IS) the male cadaver. As shown in the fi gure, phenobarbital could be detected from urine samples in actual cases. The phenobarbital concentrations in urine samples from the male and female cadavers were 23.3 and 13.5 μg/ml, respectively.
Conclusions
In this report, we have presented an HPLC method for analysis of some barbiturates in human urine using a new type of separation column. The property of this column changes according to temperature; at 10°C, the surfaces of the column packing beads are hydrophilic and change to hydrophobic according to the increase in column temperature up to 50°C (Fig. 1B) . This change can be used to control the retention time and separation of some drugs (Fig. 2) . Such thermoresponsive polymer columns seem to have great potential in forensic toxicology; it may be usable for HPLC and for combination with mass spectrometry to analyze a number of other drugs and poisons present in various matrices. This line of experiments is currently under way in our laboratories.
